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MinireviewFrom the Yolk Sac to the Spleen:
New Roles for Notch in Regulating
Hematopoiesis
The first multipotent hematopoietic progenitors are
found in the YS around E8.5 and thereafter in the para-
aortic splanchnopleura (P-Sp) or aorta/gonad/meso-
nephros (AGM) region, where they differentiate from
ventral mesoderm before colonizing the liver, and ulti-
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hemangioblasts remains debatable, early hematopoietic611 BRB II/III, 421 Curie Boulevard
and endothelial progenitors are closely related in bothPhiladelphia, Pennsylvania 19104
the YS and the P-Sp region, where cells with shared
hematopoietic and vascular markers have been identi-
fied. In their study, Kumano et al. use P-Sp explant
Although Notch receptors are widely expressed during cultures as an assay for early hematopoietic differentia-
hematopoiesis, their roles outside of the T cell lineage tion, together with transfer of progenitors to suitably
are not well characterized. Two reports in this issue conditioned recipients to assess stem cell activity. Char-
of Immunity show that Notch1 and Notch2, respec- acterization of Notch receptor expression in P-Sp shows
tively, are required to generate the earliest embryonic that Notch1 and Notch4 but not Notch2 are coexpressed
hematopoietic stem cells and splenic marginal zone with the endothelial marker Flk-1, while hematopoietic
B cells. Thus, different Notch receptors have specific cells emerging from the culture express Notch1 and
and nonoverlapping functions that influence multiple Notch2 but not Notch4. Major differences between
hematopoietic lineages at various stages of develop- Notch1 knockout and wild-type P-Sp cultures were
ment. observed, while Notch2 knockout embryos were not dif-
ferent from controls. In the absence of Notch1, P-Sp
explants had markedly impaired vascular network for-Notch signaling is an evolutionarily conserved pathway
mation, consistent with a role of Notch1 in angiogenesis,controlling many developmental cell fate decisions. In
while vascular beds reflective of vasculogenesis werehematopoiesis, Notch is required for T cell commitment
preserved. Strikingly, sharply reduced numbers of he-and has been postulated to influence multiple other
matopoietic colony forming cells (CFCs) were recoveredevents, including hematopoietic stem cell (HSC) homeo-
from Notch1 knockout P-Sp cultures, indicating impair-stasis and marginal zone B cell (MZB) development.
ment of definitive hematopoiesis. Interestingly, close toTwo reports in this issue of Immunity, Kumano et al.
normal numbers of CFCs were obtained from Notch1and Saito et al., provide new insights into the function
knockout YS, suggesting that primitive hematopoiesisof Notch signaling in HSCs and MZB cells. In early hema-
is at least partially preserved. However, cells recoveredtopoiesis, Notch1 appears critical for the generation of
from both YS and P-Sp of Notch1 knockout embryosHSCs, whereas Notch2 is required for MZB cell develop-
showed no detectable reconstitution of conditionedment in the spleen.
newborn recipients, suggesting that Notch1 is crucialMice with a targeted disruption of Notch1 develop
for generating true stem cells. The defect was cell auton-multiple defects, including abnormal somitogenesis and
omous since mixed knockout and wild-type cultures didimpaired vascular development, a defect that may di-
not rescue the phenotype. The data correlated well withrectly contribute to embryonic lethality before E11.5
experiments using -secretase inhibitors (GSI) to inhibit(Swiatek et al., 1994; Conlon et al., 1995). Conditional
Notch in P-Sp cultures, with rescue by a constitutiveinactivation of Notch1 avoids such lethality, providing
form of Notch. Interestingly, no impairment in the gener-the opportunity to characterize the role of Notch1 in
ation of hematopoietic cells was observed when thespecific organ systems (for example, see Radtke et al.,
P-Sp were obtained from E10.5 embryos, a time point1999). This approach has revealed the critical role of
when hematopoietic progenitors with stem cell potentialNotch1 in the T/B lineage decision during lymphoid de-
are already present.velopment, while most other aspects of hematopoiesis
Altogether, these results suggest that Notch1 is criti-were unaffected, including the ability to competitively
cal for the genesis of HSCs, while not being requiredrepopulate mixed bone marrow chimeras (Radtke et al.,
once their pool has been established. This situation
1999). Similar findings were observed in mice after dele-
bears striking similarities to the role of other genes in
tion of a floxed allele of CSL/RBP-Jk (CSL), a transcrip-
early hematopoietic and vascular development. For ex-
tion factor that mediates most of the well-characterized ample, mice with a targeted inactivation of SCL/tal-1
effects of Notch (Han et al., 2002). have no primitive and definitive hematopoiesis, as well
In this issue of Immunity, Kumano et al. closely evalu- as angiogenic defects (reviewed in Orkin and Zon, 2002).
ate early hematopoiesis in Notch1 and Notch2 knockout However, conditional inactivation of SCL/tal-1 does not
embryos. Blood cell formation starts with primitive he- result in detectable impairment of HSC function at later
matopoiesis in the extraembryonic yolk sac (YS), fol- time points (Mikkola et al., 2003). In the case of Notch,
lowed by definitive hematopoiesis in the embryo itself these results contrast with previous data suggesting a
(reviewed by Orkin and Zon, 2002; Kondo et al., 2003). role of Notch in HSC self-renewal (Stier et al., 2002;
Kunisato et al., 2003; reviewed in Ohishi et al., 2003).
However, these reports involved hyperactivation of the*Correspondence: wpear@mail.med.upenn.edu
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cently by experiments including loss of function ap-
proaches (Bhardwaj et al., 2001; Reya et al., 2003). The
precise molecular relationship between Notch and these
pathways in HSC biology has not been defined, although
there is suggestive evidence that they may lie in a hierar-
chy (Reya et al., 2003).
In terms of molecular mechanisms, it will be important
to characterize the precise interrelationships between
Notch and other molecules known to be involved in the
generation of early hematopoietic progenitors, such as
the transcription factors SCL/Tal-1, GATA-2, LMO2,
AML1, HoxB4, and the VEGF receptor Flk-1 (Orkin and
Zon 2002; Kondo et al., 2003). Kumano et al. show that
the expression of many of these factors is downregu-
lated in the absence of Notch1, suggesting that Notch
may function as a master switch in the early hematopoi-
etic differentiation program. This may have special rele-
vance since Notch is a transmembrane receptor able to
provide critical environmental signals to the early stem
cells. Where these signals come from, and what are
the relevant Notch ligands and ligand-expressing cells
during early hematopoietic differentiation will be another
important question to address. The mechanisms by
which Notch affects vascular development also need to
be better understood.
In contrast to the essential role of Notch1 in early HSC
and T cell development, Saito et al. show that Notch2
is critical for MZB development. A dramatic decrease
in MZB has been reported in conditional CSL knockoutFigure 1. Multiple Roles for Notch in Hematopoiesis
mice (Tanigaki et al., 2002), strongly suggesting involve-
(A) Notch signaling plays distinct roles at several stages of hemato-
ment of the Notch pathway. Because CSL is a transcrip-poietic development. During early hematopoiesis in the embryo,
tional repressor in the absence of Notch, it was unclearNotch1 is critical for the generation of cells with a hematopoietic
whether the defect resulted from loss of repression orstem cell potential from presumed hemangioblasts. It also plays a
critical role later during vascular development, beyond vasculogen- absence of Notch signals. Indirect evidence supporting
esis, although the mechanisms are unknown. During lymphopoiesis, the latter was that mice lacking MINT, a putative Notch
Notch1 signaling is required for T lineage specification and its ab- negative regulator, showed an increase in MZB cells
sence allows the development of the B lineage. While it is widely
(Kuroda et al., 2003). Significantly, this manuscript alsoaccepted that there is a CLP population that gives rise to the
showed that Notch2 was highly expressed in the spleniclymphoid lineage, a recent report identified a CLP-independent pro-
MZ. Saito et al., using conditional inactivation of Notch2,genitor population (ETP) with a high propensity for T cell develop-
ment (Allman et al., 2003). The role of Notch signaling is less clear definitively show that Notch2 is required for MZB devel-
in subsequent stages of T cell development and function. During opment through cell autonomous mechanisms. The
splenic B cell development, Notch2 signaling is required for the level of Notch2 expression appears important, as het-
generation of MZB cells. HSC, hematopoietic stem cell; CMP, com- erozygous mice have an 50% decrease in MZB cells,
mon myeloid progenitor; CLP, common lymphoid progenitor; ETP,
in contrast to the Notch1-mediated T/B lineage decisionearly T cell progenitor; T, T cells; B, B cells; NK, nature killer cells;
where haploinsufficiency has not been observed. SinceTr. B, transitional B cells; Fo, follicular B cells; and MZ, marginal
Notch2 is highly expressed in B lymphocytes, whereaszone B cells.
(B) Structure of the four mammalian Notch receptors (reviewed in Notch1 is expressed at very low levels, the differential
Allman et al., 2002). The Notch1 TAD is stronger than the Notch2 effect of Notch1 and Notch2 may be related to their
TAD, when analyzed by reporter assays, while this domain is absent expression pattern, as perhaps in T cell development
from Notch3 and Notch4. All four Notch receptors show similarity where Notch1 expression is high and Notch2 expression
in their extracellular domains. ECN, extracellular Notch; ICN, intra-
is low.cellular Notch; EGFR, EGF repeats; LNR, LIN Notch repeats; ANK,
MZB cells are thought to be important in T cell-inde-ankyrin repeats; NCR, Notch cytokine response region; TAD, trans-
pendent immune responses and share some character-activation domain; P, PEST domain; and M, membrane.
istics with B1 B cells (Martin and Kearney, 2002). They
are located in the spleen MZ and interspersed amongst
Notch pathway either through ligand-mediated stimula- macrophages and follicular dendritic cells. Although in-
tion or through the expression of constitutive forms of tegrin signaling is required to retain MZB cells in the
Notch. Whether physiological levels of Notch signaling MZ (Lu and Cyster, 2002), their development is poorly
are important in stem cell maintenance and activity re- understood. One hypothesis is that upon leaving the
mains to be rigorously tested, although the wealth of BM, B cells give rise to transitional T1 B cells that then
data from knockout mice so far do not suggest a major form T2 B cells and may be the precursors to both
defect (Radtke et al., 1999; Han et al. 2002). In contrast, follicular (Fo) and MZB cells (Loder et al., 1999). In condi-
HSC self-renewal may be influenced by other morpho- tional CSL KO mice, both a decrease in MZ cells and
an increase in Fo B cells were observed, while other Bgens such as Sonic Hedgehog and Wnt, as shown re-
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Stier, S., Cheng, T., Dombkowski, D., Carlesso, N., and Scadden,
2002, and references therein). Therefore, it is difficult to D.T. (2002). Blood 99, 2369–2378.
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action or regulatory molecules, such as Numb or Fringe.
In addition, very little is known about the transcriptional
regulation of the Notch receptor genes themselves,
whose expression is likely to provide a significant level
of control. Furthermore, since all four mammalian Notch
receptors bind CSL, the mechanisms by which different
receptors lead to different outcomes is not known. Un-
derstanding the details of Notch signaling in specific
contexts, as revealed by these two manuscripts, will
provide the basis for investigating these unanswered
questions.
